Medico-legal integration of molnupiravir rapid deployment during the COVID-19 pandemic: Emergency use authorization, clinical evidence, and risk of viral mutagenesis.

Tsai TH

Open source

DOI
10.1016/j.onehlt.2026.101621
Published
2026 Dec
Container
One health (Amsterdam, Netherlands)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.onehlt.2026.101621,
  title = {Medico-legal integration of molnupiravir rapid deployment during the COVID-19 pandemic: Emergency use authorization, clinical evidence, and risk of viral mutagenesis.},
  author = {Tsai TH},
  year = {2026},
  journal = {One health (Amsterdam, Netherlands)},
  doi = {10.1016/j.onehlt.2026.101621},
  url = {https://doi.org/10.1016/j.onehlt.2026.101621}
}

RIS

TY  - JOUR
TI  - Medico-legal integration of molnupiravir rapid deployment during the COVID-19 pandemic: Emergency use authorization, clinical evidence, and risk of viral mutagenesis.
AU  - Tsai TH
PY  - 2026
JO  - One health (Amsterdam, Netherlands)
DO  - 10.1016/j.onehlt.2026.101621
UR  - https://doi.org/10.1016/j.onehlt.2026.101621
ER  - 

APA

TH, T. (2026). Medico-legal integration of molnupiravir rapid deployment during the COVID-19 pandemic: Emergency use authorization, clinical evidence, and risk of viral mutagenesis.. One health (Amsterdam, Netherlands). https://doi.org/10.1016/j.onehlt.2026.101621

Source records